Alzheimer's Disease Trial, Not Yet Recruiting NCT06670820 Sponsor: National Defense Medical Center, Taiwan Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT06670820
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Mild Cognitive Impairment (a mild level of memory or thinking problems), rated at a specific level on a standard medical scale (CDR 0.5)
  • People who have been diagnosed with mild Alzheimer's Disease, rated at either of two specific levels on a standard medical scale (CDR 0.5 or 1)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had a stroke in the past
  • People who have a history of seizures that were not well controlled
  • People who have had a serious head injury that caused lasting brain or nerve damage, or who have a known abnormality in the structure of their brain
  • People who have a history of mental illness
  • People who have a history of drug abuse

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 886-987-859-907

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
National Defense Medical Center, Taiwan
Registry
ClinicalTrials.gov
Start date
31 October 2024
Est. completion
31 December 2028

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Changes in neurocognitive function test scores (Mini-Mental State Examination;MMSE) between T1 (Day 1) and T2 (Day 14), and the differences between the experimental and control groups.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov